Publications by authors named "Esther van Noort"

Article Synopsis
  • Ehealth platforms are increasingly vital for supporting self-management in COPD patients, especially during the COVID-19 pandemic; this study examines how healthcare professional involvement affects patients' adherence to such platforms.
  • The research involved 299 COPD patients, analyzing their usage of the Curavista eHealth platform, comparing those using it independently to those in a blended setting with professional support.
  • Results indicated that patients in a blended setting submitted questionnaire responses 3.25 times more frequently, with hospital care showing even higher adherence compared to primary care, highlighting the importance of blended care for effective self-management in COPD.
View Article and Find Full Text PDF
Article Synopsis
  • The impact of COVID-19 has raised concerns about its long-term mental and physical effects, particularly in the Netherlands where there were significant cases, hospitalizations, and deaths during the pandemic.
  • The study aims to create an online assessment tool called ABCoV to evaluate the long-term burden of COVID-19 on patients, inspired by existing tools for chronic obstructive pulmonary disease.
  • By January 2021, over 2500 patients utilized the ABCoV tool, providing valuable data that may help understand the ongoing challenges faced by COVID-19 survivors.
View Article and Find Full Text PDF

Background: Empowerment helps persons with a chronic disease to self-manage their condition and increase their autonomy and participation. MSmonitor (Curavista bv) is an interactive Web-based program for self-management and multidisciplinary care in multiple sclerosis (MS). It includes, among others, short questionnaires on fatigue (Modified Fatigue Impact Scale-5 [MFIS-5]) and health-related quality of life (HRQoL, Leeds Multiple Sclerosis Quality of Life [LMSQoL]); long questionnaires on disabilities, perception of disabilities (Multiple Sclerosis Impact Profile), and HRQoL (Multiple Sclerosis Quality of Life-54); a Medication and Adherence Inventory and an Activity Diary.

View Article and Find Full Text PDF

Background: Direct-to-patient research via Web-based questionnaires is increasingly being used. Missed data or delayed reporting of data may negatively affect the quality of study results. It is insufficiently known to what degree patients adhere to agreed self-assessment schedule over the long term and whether questionnaires are filled out in a timely manner.

View Article and Find Full Text PDF

Background: In multiple sclerosis patients, the persistence of, and adherence to, disease-modifying treatment are often insufficient. The degree of persistence and adherence may relate to the care received from various disciplines.

Methods: In an observational study of 203 patients treated with glatiramer acetate 20 mg subcutaneous daily, we assess the persistence and adherence in relation to the amount of care received in various disciplines.

View Article and Find Full Text PDF

Background: MSmonitor is an interactive web-based program for self-management and integrated, multidisciplinary care in multiple sclerosis.

Methods: To assess the utilization and valuation by persons with multiple sclerosis, we held an online survey among those who had used the program for at least 1 year. We evaluated the utilization and meaningfulness of the program's elements, perceived use of data by neurologists and nurses, and appreciation of care, self-management, and satisfaction.

View Article and Find Full Text PDF

Background: There is a growing need to offer persons with multiple sclerosis (PwMS) possibilities for self-management and to integrate multidisciplinary health data. In 2009-2014 we developed a patient-reported outcome based, interactive, web-based program (MSmonitor) for (self-)monitoring, self-management and integrated, multidisciplinary care in MS.

Methods: The notions underlying the MSmonitor concept and the program's elements are described.

View Article and Find Full Text PDF

Background: In the past two decades the widespread use of disease modifying drugs with moderate to strong efficacy has changed the natural course of multiple sclerosis (MS). Health care professionals, researchers, patient organizations and health authorities are in need of recent information about the objectified and subjective long-term clinical outcomes in MS patients. Such information is scarce.

View Article and Find Full Text PDF